Sidney Cline, APRN
Payments from drug & device makers
Across 77 payments — averaging $51.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- AbbVie$141
- Novo Nordisk$126
- Abbott$69
- AstraZeneca$63
- Johnson & Johnson$57
- plus $331 from 12 others
What the payments were for
- Travel & lodging$2,28958%
- Food & beverage$1,64142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $3,142 |
| AbbVie | 10 | $141 |
| Novo Nordisk | 7 | $126 |
| Abbott | 3 | $69 |
| AstraZeneca | 5 | $63 |
| Johnson & Johnson(2 entities) | 3 | $57 |
| Lilly USA, LLC | 4 | $54 |
| Boehringer Ingelheim | 4 | $54 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Exact Sciences | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $20 |
| Novartis | 1 | $16 |
| Pfizer | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $11 |
| Esperion Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,190
- INPEN SMART INSULIN DELIVERY SYSTEM$1,038
How this compares
$3,930 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $121,683 |
| MounjaroTirzepatide | 39 | $41,634 |
| Tresiba Flextouch U-200Insulin Degludec | 43 | $39,288 |
| TradjentaLinagliptin | 22 | $32,550 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 43 | $27,754 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $24,705 |
| FarxigaDapagliflozin Propanediol | 13 | $19,558 |
| XareltoRivaroxaban | 18 | $18,474 |
| LinzessLinaclotide | 24 | $17,997 |
| VascepaIcosapent Ethyl | 21 | $16,704 |
| EliquisApixaban | 13 | $16,362 |
| JardianceEmpagliflozin | 15 | $14,887 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $12,662 |
| EntrestoSacubitril/Valsartan | 11 | $9,717 |
| Emgality PenGalcanezumab-Gnlm | 12 | $7,690 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $126 | $128,55093 claims |
| Boehringer IngelheimTradjenta, Jardiance | $54 | $47,43737 claims |
| Lilly USA, LLCMounjaro | $54 | $41,63439 claims |
| AstraZenecaFarxiga | $63 | $19,55813 claims |
| Johnson & JohnsonXarelto | $57 | $18,47418 claims |
| AbbVieLinzess | $141 | $17,99724 claims |
| PfizerEliquis | $14 | $16,36213 claims |
| NovartisEntresto | $16 | $9,71711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.
Other family in Logan
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
- Misty BareboHuntington$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.